Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Impact of Superspreaders on dissemination and mitigation of COVID-19

Kim Sneppen, View ORCID ProfileLone Simonsen
doi: https://doi.org/10.1101/2020.05.17.20104745
Kim Sneppen
1University of Copenhagen, Niels Bohr Institute, 2100 København Ø, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ksneppen@gmail.com
Lone Simonsen
2University of Roskilde, Department of Science and Environment, 4000 Roskilde, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lone Simonsen
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The severity of the Covid-19 pandemic has led to the use of extreme control measures which has halted the spread, but at enormous socioeconomic cost. We set out to explore whether a model that includes ‘superspreader’ could explain aspects of mitigation strategies that explain the dramatic effect.

Methods We developed an age structured agent-based model that includes persons who spread the disease far more widely than others, acting in a society in which transmission occurs in three sectors: home, school/work and a third category representing other social contacts. We employ the model to study the impact of lock-down when superspreaders are present.

Findings As expected, without mitigation imposed, the inclusion of superspreaders in the population does not change the epidemic trajectory. However in a structured society we find that superspreaders made a substantial difference. Our simulations demonstrate that workplaces and schools may open without much effect on the epidemic, as long as the other social contacts are drastically limited.

Interpretation The recent observations of profound pandemic control that cannot be captured by standard SEIR models, require disease transmission models that consider superspreaders. We have found that transmission can be controlled simply by limiting contacts such as public transportation and large events. Indeed, eliminating superspreader opportunities can uniquely explain the observed control of the epidemic with Sweden’s relaxed approach and with the moderate lock-down used in Denmark.

Funding KS received funding from the EU Horizon 2020 research program under ERC grant No. 740704, and LS from the Carlsberg Foundation in Denmark.

Research in context:

Evidence before this study:

Since the emergence of SARS-CoV-2 in China, superspreaders are emerging as a theme, as it was also the case with SARS-CoV in 2003. Analyzing COVID-19 data, substantial individual-level variation in transmissibility has been inferred, and it has been estimated that 10% of infected persons cause 80% of all infections.

Added value of this study:

We developed an agent-based socially structured model to simulate the effect of superspreaders on the epidemic, and in the context of country lockdowns and reopenings. Our simulations demonstrate that COVID-19 is effectively mitigated if one limits social activity where many strangers meet, as superspreaders will infect mainly among the many people they rarely meet.

Implications of all available evidence:

Modelling heterogeneity and super spreading is critical in terms of understanding observed COVID-19 epidemic patterns. Indeed, mitigating superspreading opportunities is an effective way to mitigate Covid-19 and prevent second waves because the remaining population cannot sustain the epidemic. The superspreader phenomenon may also explain the observation of huge COVID-19 epidemic variability between different areas in the same country.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement No. 740704, and from the Carlsberg Foundation in Denmark.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB body involved here. It is a theoretical paper using publically available data from Danish, Norwegian and Swedish health authorities.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No data.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 31, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Superspreaders on dissemination and mitigation of COVID-19
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Impact of Superspreaders on dissemination and mitigation of COVID-19
Kim Sneppen, Lone Simonsen
medRxiv 2020.05.17.20104745; doi: https://doi.org/10.1101/2020.05.17.20104745
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Impact of Superspreaders on dissemination and mitigation of COVID-19
Kim Sneppen, Lone Simonsen
medRxiv 2020.05.17.20104745; doi: https://doi.org/10.1101/2020.05.17.20104745

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (942)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8969)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1322)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10769)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1818)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4109)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (363)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)